abstract |
A hemostatic composition is provided. The present invention discloses a hemostatic composition comprising a) a biocompatible polymer in particulate form suitable for use in hemostasis, and b) a hydrophilic group comprising a reactive group. A functional polymer component. The combination of the biocompatible polymer in particulate form and one hydrophilic polymer component provides a composition with improved hemostatic properties and improved tissue adhesion. This is particularly suitable for wound treatment where hemostasis induction has failed (eg, with impaired hemostasis (eg, after heparinization)). The composition according to the invention improves hemostasis. Furthermore, the composition according to the invention exhibits strong adhesion to tissue when applied to a wound. [Selection figure] None |